House Republicans Aim To Eliminate Tax Credits For Orphan Drugs

For more than three decades, pharmaceutical companies have claimed a 50 percent tax credit for the cost of clinical trials of drugs for rare diseases. The credit is now in jeopardy.(Image credit: Alex Wong/Getty Images)

Read the full post at
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive